However, excessive toxicity, including black box warnings related to gastroenteric and cardiac side effects, likely caused by potent inhibition of HDAC isoforms inconsequential in plasma cell and MM biology, has restricted effective utilization clinically. Here, HDAC9 is linked to Miyoshi myopathy.